These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17483695)

  • 1. Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome.
    Qu S; Le W; Zhang X; Xie W; Zhang A; Ondo WG
    J Neuropathol Exp Neurol; 2007 May; 66(5):383-8. PubMed ID: 17483695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation.
    Zhao H; Zhu W; Pan T; Xie W; Zhang A; Ondo WG; Le W
    J Neurosci Res; 2007 Apr; 85(5):1065-76. PubMed ID: 17342757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of restless legs syndrome.
    Ondo WG; Zhao HR; Le WD
    Sleep Med; 2007 Jun; 8(4):344-8. PubMed ID: 17468045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome.
    Ondo WG; He Y; Rajasekaran S; Le WD
    Mov Disord; 2000 Jan; 15(1):154-8. PubMed ID: 10634257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of D2 receptor mediated regulation of dopamine synthesis in A11 diencephalospinal neurons in male and female mice.
    Pappas SS; Behrouz B; Janis KL; Goudreau JL; Lookingland KJ
    Brain Res; 2008 Jun; 1214():1-10. PubMed ID: 18462709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective.
    Clemens S; Rye D; Hochman S
    Neurology; 2006 Jul; 67(1):125-30. PubMed ID: 16832090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model.
    Luo F; Li C; Ondo WG; Xu P; Xie W; Le W
    Sleep Med; 2011 Jan; 12(1):41-6. PubMed ID: 21044864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of dietary iron deprivation on murine circadian sleep architecture.
    Dean T; Allen RP; O'Donnell CP; Earley CJ
    Sleep Med; 2006 Dec; 7(8):634-40. PubMed ID: 17098470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of periodic limb movements in a putative animal model of restless leg syndrome.
    Lopes C; Esteves AM; Frussa-Filho R; Tufik S; de Mello MT
    Mov Disord; 2012 Mar; 27(3):413-20. PubMed ID: 22162115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of iron in restless legs syndrome.
    Allen RP; Earley CJ
    Mov Disord; 2007; 22 Suppl 18():S440-8. PubMed ID: 17566122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-deficit/hyperactivity disorder, Tourette's syndrome, and restless legs syndrome: the iron hypothesis.
    Cortese S; Lecendreux M; Bernardina BD; Mouren MC; Sbarbati A; Konofal E
    Med Hypotheses; 2008; 70(6):1128-32. PubMed ID: 18164140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.
    Matsukawa N; Maki M; Yasuhara T; Hara K; Yu G; Xu L; Kim KM; Morgan JC; Sethi KD; Borlongan CV
    Brain Res; 2007 Jul; 1160():113-23. PubMed ID: 17573046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary restless legs syndrome].
    Oka Y; Ioue Y
    Brain Nerve; 2009 May; 61(5):539-47. PubMed ID: 19514514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The restless legs syndrome.
    Barrière G; Cazalets JR; Bioulac B; Tison F; Ghorayeb I
    Prog Neurobiol; 2005 Oct; 77(3):139-65. PubMed ID: 16300874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restless legs syndrome: pathophysiology and the role of iron and folate.
    Patrick LR
    Altern Med Rev; 2007 Jun; 12(2):101-12. PubMed ID: 17604457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children.
    Konofal E; Cortese S; Marchand M; Mouren MC; Arnulf I; Lecendreux M
    Sleep Med; 2007 Nov; 8(7-8):711-5. PubMed ID: 17644481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the pathway of an animal model for restless legs syndrome..
    Manconi M; Hutchins W; Feroah TR; Zucconi M; Ferini-Strambi L
    Neurol Sci; 2007 Jan; 28 Suppl 1():S53-60. PubMed ID: 17235432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D3 receptor specifically modulates motor and sensory symptoms in iron-deficient mice.
    Dowling P; Klinker F; Stadelmann C; Hasan K; Paulus W; Liebetanz D
    J Neurosci; 2011 Jan; 31(1):70-7. PubMed ID: 21209191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.